BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.17
-0.04 (-3.31%)
As of Jun 30, 4:31 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,802.6% upside
Low Target $19.62
Average Target $33.96
High Target $35.69
Current Price $1.17
Current
$1.17
Target
$33.96
$19.62 $33.96 avg $35.69
Scenario Analysis
Bear Case
$19.62
1,576.9%
Low target
Base Case
$33.96
+2,802.6%
Avg target
Bull Case
$35.69
+2,950.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.45
-52.2% from high
52-Week Low
$0.78
+50.7% from low
Target vs 52W High
$33.96
+1,286.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%